RhoU is one of the rare atypical RSGs that is only palmitoylated and not isoprenylated (Table 2), and its palmytoylation is highly regulated by fatty acid synthase (FASN) [122,123], which is itself commonly overexpressed in PCa and is associated with tumor progression [124]. This evidence concerns the gene FASN and neoplasm.